ACSL6

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ACSL6 mutation is significantly associated with the RNA expression of many other genes, with 13 significant associations in total. KIDNEY shows the largest number of these associations.

The most reproducible ACSL6-associated genes across cancer lineages are PRLHR, WFDC12, and TEX48. Each is linked with ACSL6 in more than 1 cancer types. Because this analysis shows association rather than direction, both ACSL6-to-partner and partner-to-ACSL6 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, PRLHR grouped by ACSL6-low versus ACSL6-high in KIDNEY.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ACSL6→partner) and Y-score (partner→ACSL6) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
KIDNEYPRLHR →+0.030+5.000<.001.00531
KIDNEYWFDC12 →+0.066+5.000<.001.00531
KIDNEYTEX48 →+0.133+5.000<.001.00531
OESOPHAGUSANKRD30BL →+0.023+4.906<.001.00631
OESOPHAGUSDEFB4A →+0.653+4.906<.001.00631
LARGE_INTESTINEOR10W1 →+0.010+3.562<.001.00231
Each partner links to its Q-omics profile. Showing the 6 strongest of 13 associations by consensus.

PRLHR by ACSL6 expression — KIDNEY

Box plot of PRLHR in ACSL6-low vs ACSL6-high samples in KIDNEY.

Explore this box plot interactively →

Exploration